UBS analyst Colin Bristow downgrades Pfizer (NYSE:PFE) from Buy to Neutral and lowers the price target from $55 to $47.
Why Data Storage Shares Are Surging Today
Data Storage Corp (NASDAQ:DTST) reported first-quarter FY22 revenue growth of 236% year-on-year to $8.66 million, beating the consensus of $6 million.…